Determination and properties of proteohormone receptors in malignant gynecological tumors with special reference to lactogen receptors in human breast cancer
- 1 June 1980
- journal article
- research article
- Published by Springer Nature in Archiv für Gynäkologie
- Vol. 229 (4) , 333-344
- https://doi.org/10.1007/bf02108584
Abstract
Proteohormone receptors have been demonstrated in gynecological malignancies, but more sensitive methods for measurement of such receptors are required and should be a matter of intensive research. The clinical response of hormone-dependent tumors to endocrine therapy has not yet been correlated with the occurrence of proteo-hormone receptors in neoplastic tissue from gynecological patients and such studies are required.This publication has 66 references indexed in Scilit:
- PRINCIPLES OF RADIORECEPTOR ASSAY FOR PROLACTINClinical Endocrinology, 1977
- Polypeptide Hormone Receptors: Characteristics and ApplicationsCanadian Journal of Physiology and Pharmacology, 1975
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975
- Demonstration of a Specific Receptor for Prolactin in Porcine Granulosa CellsEndocrine Research Communications, 1975
- Prolactin Receptors in an Estrogen Receptor-Deficient Mammary CarcinomaScience, 1974
- PLASMA-PROLACTIN IN HUMAN BREAST CANCERThe Lancet, 1974
- Radioreceptor Assay for Prolactin and Other Lactogenic HormonesScience, 1973
- STUDIES WITH TRITIUM-LABELLED HEXŒSTROL IN ADVANCED BREAST CANCERThe Lancet, 1961
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896